128 related articles for article (PubMed ID: 36917412)
1. Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.
Sureka SK; Misra A; Raj H; Shukla A; Singh UP
Int Urol Nephrol; 2023 May; 55(5):1133-1137. PubMed ID: 36917412
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study comparing six- and twelve-core prostate biopsy in detection of prostate cancer.
Tobiume M; Yamada Y; Nakamura K; Honda N
Int Braz J Urol; 2008; 34(1):9-14. PubMed ID: 18341716
[TBL] [Abstract][Full Text] [Related]
3. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
4. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
6. Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
Queiroz MR; Falsarella PM; Moreira Valle LG; Cayres Mariotti G; Lemos GC; Alfer Junior W; Garcia RG
Acta Radiol; 2021 Jun; 62(6):815-820. PubMed ID: 32631078
[TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
Park SJ; Miyake H; Hara I; Eto H
Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
[TBL] [Abstract][Full Text] [Related]
8. Length of prostate biopsy cores: does it impact cancer detection?
Fiset PO; Aprikian A; Brimo F
Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
[TBL] [Abstract][Full Text] [Related]
9. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
10. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
Philip J; Hanchanale V; Foster CS; Javlé P
BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
[TBL] [Abstract][Full Text] [Related]
11. The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.
Nomikos M; Karyotis I; Phillipou P; Constadinides C; Delakas D
Int Braz J Urol; 2011; 37(1):87-93; discussion 93. PubMed ID: 21385484
[TBL] [Abstract][Full Text] [Related]
12. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
13. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
Dai B; Ye DW; Kong YY; Shen YJ; Wang BH
Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study.
Naughton CK; Smith DS; Humphrey PA; Catalona WJ; Keetch DW
Urology; 1998 Nov; 52(5):808-13. PubMed ID: 9801104
[TBL] [Abstract][Full Text] [Related]
15. The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density.
Chen Y; Jiang X; Liu R; Zhang Z; Luo F; Qi S; Xu Y
Med Sci Monit; 2019 Aug; 25():6230-6235. PubMed ID: 31424055
[TBL] [Abstract][Full Text] [Related]
16. Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
Albisinni S; Aoun F; Noel A; El Rassy E; Lemort M; Paesmans M; van Velthoven R; Roumeguère T; Peltier A
Prog Urol; 2018 Jan; 28(1):18-24. PubMed ID: 29203158
[TBL] [Abstract][Full Text] [Related]
17. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
18. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
Gershman B; Zietman AL; Feldman AS; McDougal WS
Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
[TBL] [Abstract][Full Text] [Related]
19. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
[TBL] [Abstract][Full Text] [Related]
20. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]